Vascular disease and stem cell therapies

British Medical Bulletin

Volumn 98, Issue 1, 2011, Pages 187-197

  Lasala, Gabriel P ^a,b   Minguell, Jose J ^a  

^a TCA Cellular Therapy   (United States)

^b NONE   (United States)

Author keywords

cell therapy; clinical trials; limb ischemia; therapeutic angiogenesis

Indexed keywords

FIBROBLAST GROWTH FACTOR; GRANULOCYTE COLONY STIMULATING FACTOR; PLATELET DERIVED GROWTH FACTOR; VASCULOTROPIN;

ANGIOGENESIS; ANKLE BRACHIAL INDEX; ARTICLE; BLOOD VESSEL PERMEABILITY; CELL MIGRATION; CELL PROLIFERATION; CELL TYPE; CLINICAL EFFECTIVENESS; CLINICAL EVALUATION; EMBRYONIC STEM CELL; ENDOTHELIUM CELL; EXTRACELLULAR MATRIX; HEART INFARCTION; HEMATOPOIETIC STEM CELL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IMMUNOPHENOTYPING; LIMB ISCHEMIA; MEDICAL LITERATURE; MESENCHYMAL STEM CELL; MESENCHYMAL STEM CELL TRANSPLANTATION; MONONUCLEAR CELL; NONHUMAN; OXYGEN TENSION; PATIENT SAFETY; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; STEM CELL TRANSPLANTATION; VASCULAR DISEASE; VASCULAR SMOOTH MUSCLE;

CLINICAL TRIALS AS TOPIC; ENDOTHELIAL CELLS; EXTREMITIES; HUMANS; ISCHEMIA; MESENCHYMAL STEM CELL TRANSPLANTATION; STEM CELL TRANSPLANTATION; TREATMENT OUTCOME;

EID: 79958792745     PISSN: 00071420     EISSN: 14718391     Source Type: Journal    
DOI: 10.1093/bmb/ldr017     Document Type: Article

References (38)

1. Feiring AJ, Krahn M, Nelson L. Preventing leg amputation in critical limb ischemia with below the knee drug-eluting stents: the PaRADISE Trial. J Am Coll Cardiol 2010;55:1580-89.
2. Tateishi-Yuyama E, Matsubara H, Murohara T et al. Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial. Lancet 2002;360 427-35.
3. Saigawa T, Kato K, Ozawa T et al. Clinical application of bone marrow implantation in patients with arteriosclerosis obliterans, and the association between efficacy and the number of implanted bone marrow cells. Circ J 2004;68:1189-93. (Pubitemid 40018866)
4. Miyamoto M, Yasutake M, Takano H et al. Therapeutic angiogenesis by autologous bone marrow cell implantation for refractory chronic peripheral arterial disease using assessment of neovascularization neovascularization by 99mTc-tetrofosmin (TF) perfusion scintigraphy. Cell Transplant 2004;13:429-37. (Pubitemid 39163088)
5. Nizankowski R, Petriczek T, Skotnicki A et al. The treatment of advanced chronic lower limb ischaemia with marrow stem cell autotransplantation. Kardio Pol 2005;63:351-60. (Pubitemid 41624880)
6. Kawamura A, Horie T, Tsuda I et al. Prevention of limb amputation in patients with limbs ulcers by autologous peripheral blood mononuclear cell implantation. Ther Apher Dial 2005;9:59-63. (Pubitemid 40393326)
7. Bartsch T, Brehm M, Zeus T et al. Transplantation of autologous mononuclear bone marrow stem cells in patients with peripheral arterial disease (the TAM-PAD study). Clin Res Cardiol 2007;96:891-9. (Pubitemid 350164931)
8. Cobellis G, Silvestroni A, Lillo S et al. Long-term effects of repeated autologous transplantation of bone marrow cells in patients affected by peripheral arterial disease. Bone Marrow Transplant 2008;42:667-72.
9. Matoba S, Tatsumi T, Murohara T et al. Long-term clinical outcome after intramuscular implantation of bone marrow mononuclear cells (Therapeutic Angiogenesis by Cell Transplantation [TACT] trial) in patients with chronic limb ischemia. Am Heart J 2008;156:1010-18.
10. Burt RK, Testori A, Oyama Y et al. Autologous peripheral blood CD133\+ cell implantation for limb salvage in patients with critical limb ischemia. Bone Marrow Transplant 2010;45:111-6.
11. Lasala GP, Silva JA, Gardner PA et al. Combination of stem cell therapy for the treatment of severe limb ischemia. Angiology 2010;61:551-6.
12. Asahara T, Masuda H, Takahashi T et al. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res 1999;85:221-8. (Pubitemid 29377293)
13. Zammaretti P, Zisch AH. 'Adult endothelial progenitor cells'. Renewing vasculature. Int J Biochem Cell Biol 2005;37:493-503. (Pubitemid 40022924)
14. Milkiewicz M, Ispanovic E, Doyle JL et al. Regulators of angiogenesis and strategies for their therapeutic manipulation. Int J Biochem Cell Biol 2006;38:333-57. (Pubitemid 41821882)
15. Kässmeyer S, Plendl J, Custodis P et al. New insights in vascular development: vasculogenesis and endothelial progenitor cells. Anat Histol Embryol 2009;38:1-11.
16. Leone AM, Valgimigli M, Giannico MB et al. From bone marrow to the arterial wall: the ongoing tale of endothelial progenitor cells. Eur Heart J 2009;30:890-9.
17. Dvorak HF. Angiogenesis: update 2005. J Thromb Haemost 2005;3:1835-42. (Pubitemid 41716570)
18. Byrne AM, Bouchier-Hayes DJ, Harmey JH. Angiogenic and cell survival functions of vascular endothelial growth factor (VEGF). J Cell Mol Med 2005;9:777-94. (Pubitemid 43116546)
19. Timmermans F, Plum J, Yö der MC et al. Endothelial progenitor cells: identity defined?. J Cell Mol Med 2009;13:87-102.
20. Cao Y. Wake-up call for endothelial cells. Blood 2010;115:2336-7.
21. Yeo C, Saunders N, Locca D et al. Ficoll-Paque versus Lymphoprep: a comparative study of two density gradient media for therapeutic bone marrow mononuclear cell preparations. Regen Med 2009;4:689-96.
22. Lanza F, Campioni D, Moretti S et al. CD34(\+) cell subsets and long-term culture colonyforming cells evaluated on both autologous and normal bone marrow stroma predict longterm hematopoietic engraftment in patients undergoing autologous peripheral blood stem cell transplantation. Exp Hematol 2001;29:1484-93. (Pubitemid 34007624)
23. Yin AH, Miraglia S, Zanjani ED et al. AC133, a novel marker for human hematopoietic stem and progenitor cells. Blood 1997;90:5002-12. (Pubitemid 28007217)
24. NIH. Stem cells markers. http://stemcells.nih.gov/info/scireport/ appendixe.asp#eii.
25. Minguell JJ, Erices A, Conget P. Mesenchymal stem cells. Exp Biol Med 2001;226:507-20. (Pubitemid 32524497)
26. Poncelet AJ, Hiel AL, Vercruysse J et al. Intracardiac allogeneic mesenchymal stem cell transplantation elicits neo-angiogenesis in a fully immunocompetent ischaemic swine model. Eur J Cardiothorac Surg 2010;38:781-7.
27. Blau HM, Banfi A. The well-tempered vessel. Nat Med 2001;7:532-4. (Pubitemid 32448310)
28. Bexell D, Gunnarsson S, Tormin A et al. Bone marrow multipotent mesenchymal stroma cells act as pericyte-like migratory vehicles in experimental gliomas. Mol Ther 2009;17:183-90.
29. Covas DT, Panepucci RA, Fontes AM et al. Multipotent mesenchymal stromal cells obtained from diverse human tissues share functional properties and gene-expression profile with CD146\+ perivascular cells and fibroblasts. Exp Hematol 2008;36:642-54.
30. Campagnolo P, Cesselli D, Al Haj Zen A et al. Human adult vena saphena contains perivascular progenitor cells endowed with clonogenic and proangiogenic potential. Circulation 2010;121:1735-45.
31. Chichester CO, Fernández M, Minguell JJ. Extracellular matrix gene expression by human bone marrow stroma and by marrow fibroblasts. Cell Adhes Commun 1993;1:93-9,21.
32. Pittenger MF, Mackay AM, Beck SC et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999;284:143-7. (Pubitemid 29282067)
33. Minguell JJ, Erices A. Mesenchymal stem cells and the treatment of cardiac disease. Exp Biol Med 2006;231:39-49. (Pubitemid 43063975)
34. da Silva Meirelles L, Caplan AI, Nardi NB. In search of the in vivo identity of mesenchymal stem cells. Stem Cells 2008;26:2287-99.
35. Le Blanc K, Tammik C, Rosendahl K et al. HLA expression and immunologic properties of differentiated and undifferentiated mesenchymal stem cells. Exp Hematol 2003;31:890-9.
36. Falstie-Jensen N, Brøchner-Mortensen J, Spaun E et al. The influence of epidermal thickness on transcutaneous oxygen pressure measurements. Scand J Clin Lab Invn 1988;48:519-23.
37. Amin AH, Abd Elmageed ZY, Nair D et al. Modified multipotent stromal cells with epidermal growth factor restore vasculogenesis and blood flow in ischemic hind-limb of type II diabetic mice. Lab Invest 2010;90:985-96.
38. Mizuno H, Miyamoto M, Shimamoto M et al. Therapeutic angiogenesis by autologous bone marrow cell implantation together with allogeneic cultured dermal substitute for intractable ulcers in critical limb ischaemia. J Plast Reconstr Aesthet Surg. 2010;63:1875-82.